1. Home
  2. ALKT vs ANIP Comparison

ALKT vs ANIP Comparison

Compare ALKT & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alkami Technology Inc.

ALKT

Alkami Technology Inc.

HOLD

Current Price

$14.43

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$73.00

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALKT
ANIP
Founded
2007
2001
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
2021
1999

Fundamental Metrics

Financial Performance
Metric
ALKT
ANIP
Price
$14.43
$73.00
Analyst Decision
Buy
Buy
Analyst Count
8
9
Target Price
$19.86
★ $105.78
AVG Volume (30 Days)
★ 2.0M
297.3K
Earning Date
10-28-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 419.23
EPS
N/A
★ 2.32
Revenue
$152,159,000.00
★ $206,547,000.00
Revenue This Year
$19.44
$24.85
Revenue Next Year
$16.64
$10.76
P/E Ratio
★ N/A
$31.35
Revenue Growth
★ 35.68
2.47
52 Week Low
$13.21
$69.58
52 Week High
$24.47
$96.99

Technical Indicators

Market Signals
Indicator
ALKT
ANIP
Relative Strength Index (RSI) 33.03 48.22
Support Level $13.21 $69.87
Resistance Level $14.52 $83.03
Average True Range (ATR) 0.48 1.92
MACD 0.13 0.02
Stochastic Oscillator 35.16 57.85

Price Performance

Historical Comparison
ALKT
ANIP

About ALKT Alkami Technology Inc.

Alkami Technology Inc is a cloud-based digital banking solutions provider. The company offers the Alkami Digital Sales & Service Platform, which includes a digital banking platform, onboarding and account opening solutions, and data and marketing tools. The platform enables financial institutions to onboard and engage users, support revenue growth, and improve operational efficiency through a cloud-based, multi-tenant architecture. The company provides services to clients under software-as-a-service arrangements. It derives substantially all of its revenues from SaaS subscription services charged for the use of digital sales and service solutions.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: